| An aluminum hydroxide: CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice E Nanishi, F Borriello, TR O’Meara, ME McGrath, Y Saito, RE Haupt, ... Science translational medicine 14 (629), eabj5305, 2021 | 83* | 2021 |
| Evolution of bacterial cross-resistance to lytic phages and albicidin antibiotic KE Kortright, S Doss-Gollin, BK Chan, PE Turner Frontiers in microbiology 12, 658374, 2021 | 19* | 2021 |
| Heterogeneous development of children with Congenital Zika Syndrome-associated microcephaly JP Aguilar Ticona, N Nery Jr, S Doss-Gollin, C Gambrah, M Lessa, ... PLoS One 16 (9), e0256444, 2021 | 16 | 2021 |
| CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns SD van Haren, GK Pedersen, A Kumar, TJ Ruckwardt, S Moin, IN Moore, ... Nature Communications 13 (1), 4234, 2022 | 11 | 2022 |
| Risk of sexually transmitted Zika virus in a cohort of economically disadvantaged urban residents JP Aguilar Ticona, H Baig, N Nery Jr, S Doss-Gollin, GA Sacramento, ... The Journal of Infectious Diseases 224 (5), 860-864, 2021 | 11 | 2021 |
| Immunogenicity of a three-dose primary series of mRNA COVID-19 vaccines in patients with lymphoid malignancies AC Sherman, JL Crombie, CA Cheng, M Desjardins, G Zhou, ... Open Forum Infectious Diseases 9 (8), ofac417, 2022 | 9 | 2022 |
| Social determinants associated with Zika virus infection in pregnant women N Nery Jr, JP Aguilar Ticona, C Gambrah, S Doss-Gollin, A Aromolaran, ... PLoS Neglected Tropical Diseases 15 (7), e0009612, 2021 | 8 | 2021 |
| Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen S Doss-Gollin, S Thomas, B Brook, K Abedi, C Lebas, F Auderset, ... npj Vaccines 8 (1), 163, 2023 | 2 | 2023 |
| Human In vitro Modeling Identifies Adjuvant Combinations that Unlock Antigen Cross-presentation and Promote T-helper 1 Development in Newborns, Adults and Elders S Thomas, J Pak, S Doss-Gollin, K Ryff, E Beijnen, GK Pedersen, ... Journal of Molecular Biology 436 (4), 168446, 2024 | 1 | 2024 |
| Lessons from the Bolivian vaccine mandate DRZ Rivas, JPA Ticona, S Doss-Gollin Vaccine 41 (27), 3951, 2023 | | 2023 |
| 1174. Liposomal Co-Formulation of MPL and QS-21 Favors the Development of T-helper 1 Cells and Promotes the Induction of CD8+ T Cells Against SARS-CoV-2 SD van Haren, S Thomas, O Levy, G Sanchez-Schmitz, S Doss-Gollin, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1011, 2022 | | 2022 |
Ofer LevyDirector, Precision Vaccines Program & Principal Investigator, Boston Children's Hospital在 childrens.harvard.edu 的电子邮件经过验证
